N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) G1001C polymorphism and susceptibility to schizophrenia: A meta-analysis

EXCLI Journal

Volumn 9, Issue , 2010, Pages 11-16

  Saadat, Mostafa ^a  

^a SHIRAZ UNIVERSITY   (Iran)

Author keywords

Case control study; Genetic polymorphism; Grin1; Meta analysis

Indexed keywords

EID: 77950902277     PISSN: None     EISSN: 16112156     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Begni S, Moraschi S, Bignotti S, Fumagalli F, Rillosi L, Perez J, Gennarelli M (2003). Association between the G1001C polymor-phism in the GRIN1 gene promoter region and schizophrenia. Biol Psychiatry 2003; 53:617-9.
2. Belsham B. Glutamate and its role in psychiatric illness. Hum Psychopharmacol 2001;16:139-46.
3. Betcheva ET, Mushiroda T, Takahashi A, Kubo M, Karachanak SK, Zaharieva IT, Vazharova RV, Dimova II, Milanova VK, Tolev T, Kirov G, Owen MJ, O'Donovan MC, Kamatani N, Nakamura Y, Toncheva DI. Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. J Hum Genet 2009;54:98-107.
4. Brett PM, Le Bourdelles B, See CG, Whiting PJ, Attwood J, Woodward K, Robertson MM, Kalsi G, Povey S, Gurling HM. Ge-nomic cloning and localization by FISH and linkage analysis of the human gene en-coding the primary subunit NMDAR1 (GRIN1) of the NMDA receptor channel. Ann Hum Genet 1994;58:95-100.
5. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7: 177-88.
6. Galehdari H, Pooryasinm A, Forough-mandm A, Daneshmand S, Saadat M. (2009). Association between the G1001C polymorphism in the GRIN1 gene promoter and schizophrenia in the Iranian population. J Mol Neurosci 2009;38:178-81. Erratum in: J Mol Neurosci 2009;37:95.
7. Gao XM, Sakai K, Roberts RC, Conley RR, Dean B, Tamminga CA. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am J Psychiatry 2000;157:1141-9.
8. Georgi A, Jamra RA, Klein K, Villela AW, Schumacher J, Becker T, Paul T, Schmael C, Höfels S, Klopp N, Illig T, Propping P, Cichon S, Nöthen MM, Schulze TG, Riet-schel M. Possible association between genetic variants at the GRIN1 gene and schizophrenia with lifetime history of depressive symptoms in a German sample. Psychiatr Genet 2000;17:308-10.
9. Hu Z, Ma H, Chen F, Wei Q, Shen H. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 2005;14:1810-8.
10. Ibrahim HM, Hogg AJ, Jr Healy DJ, Harou-tunian V, Davis KL, Meador-Woodruff JH. Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. Am J Psychiatry 2000; 157:1811-23.
11. Kiyohara C, Takayama K, Nakanishi Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer, 2006;54:267-83.
12. Li ZJ, Wang BJ, Ding M, Pang H, Sun XF, Yang J. [The association between glutamate receptor gene SNP and schizophrenia]. Fa Yi Xue Za Zhi 2008;24:369-74 [in Chinese].
13. Little J, Higgins JP, Ioannidis JP, et al. STrengthening the REporting of Genetic Association studies (STREGA)-an exten-sion of the STROBE statement. Eur J Clin Invest 2009;39:247-66.
14. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22: 719-48.
15. Martucci L, Wong AH, Trakalo J, Cate-Carter T, Wong GW, Macciardi FM, Ken-nedy JL. N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) in schizophre-nia: TDT and case-control analyses. Am J Med Genet B Neuropsychiatr Genet 2003;119B: 24-7.
16. Mohn AR, Gainetdinov RR, Caron MG, Koller BH. Mice with reduced NMDA re-ceptor expression display behaviors related to schizophrenia. Cell 1999;98:427-36.
17. Qin S, Zhao X, Pan Y, Liu J, Feng G, Fu J, Bao J, Zhang Z, He L. An association study of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with uni-versal DNA microarray. Eur J Hum Genet 2005;13:807-14.
18. Saadat M. Genetic polymorphisms of glu-tathione S-transferase T1 (GSTT1) and sus-ceptibility to gastric cancer: a meta-analysis. Cancer Sci 2006;97:505-9.
19. Saadat M, Ansari-Lari M. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the litera-tures. Breast Cancer Res Treat 2009;115: 137-44.
20. Sokolov BP. Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of neuroleptic-free schizophrenics: evidence on reversible up-regulation by typical neuroleptics. J Neurochem 1998;71: 2454-64.
21. Zhao X, Li H, Shi Y, Tang R, Chen W, Liu J, Feng G, Shi J, Yan L, Liu H, He L. Sig-nificant association between the genetic variations in the 5' end of the N-methyl-D aspartate receptor subunit gene GRIN1 and schizophrenia. Biol Psychiatry 2006;59: 747-53.